Skip to content

The Effect on Cerebral Oxygenation of Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit in Cardiac Surgery Patients

The Effect on Cerebral Oxygenation of Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit in Cardiac Surgery Patients: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02108093
Acronym
RAP
Enrollment
220
Registered
2014-04-09
Start date
2014-12-31
Completion date
2015-12-31
Last updated
2014-12-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Brief summary

The effect of retrograde autologous priming (RAP) on regional cerebral oxygenation (rSO2) still remains unclear, because studies are limited in sample size and study design, and because of the absence of prospective studies. The investigators hypothesize that RAP limits the degree of hemodilution and thereby limits prolonged intraoperative cerebral desaturation during cardiopulmonary bypass (CPB), compared to the conventional priming method. The primary objective of this study is to determine whether RAP limits the degree of hemodilution and limits prolonged intraoperative cerebral desaturation during cardiopulmonary bypass, compared to the conventional priming method. Prolonged intraoperative cerebral desaturation will be assessed by rSO2 desaturation score50. rSO2 desaturation score50 \> 3000 is associated with increased risk of cognitive decline. The investigators hypothesize that RAP limits the degree of hemodilution and thereby limits the incidence of rSO2 desaturation score50 \> 3000 with a relative difference of 50%. The subjects who are divided in the RAP group, the retrograde autologous priming technique will be used, where the patient's own circulating blood partially will be replaced by the priming solution in the cardiopulmonary bypass. In the Control group the conventional priming method will be used. The main study parameters is rSO2 desaturation score50.

Interventions

Retrograde autologous priming (RAP) is a technique where, the patient's own circulating blood partially replaces the priming solution in the CPB.

Sponsors

Amphia Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective combined cardiac surgical procedures

Exclusion criteria

* Elective single cardiac surgical procedures * off-pump procedure * re-operation * emergency operation * methylene blue administration

Design outcomes

Primary

MeasureTime frameDescription
prolonged intraoperative cerebral desaturationParticipants will be followed for the duration of the operation period, an expected average of 3 hoursThe primary study parameter of this study is prolonged intraoperative cerebral desaturation and will be assessed by rSO2 desaturation score50. rSO2 desaturation score50 \> 3000 is associated with increased risk of cognitive decline. Formula described by Slater et al. : rSO2 score = 50% rSO2 - current rSO2 (%) x time (s) will be used to calculate the rSO2 score; from the intraoperative cerebral oximetry data.

Secondary

MeasureTime frameDescription
cerebral oxygenation desaturation episodes (CODE)participants will be followed for the duriation of the operation period, an expected average of 3 hoursCODE will be defined by a reduction of 20% baseline value of rSO2 at least one minute or an absolute reduction of 50%
Subjective Cognitive Failure Questionnaire (CFQ)3 months and 6 months after randomizationThree and six months after randomization the Subjective CFQ will be sent to the patients to evaluate cognition.
blood transfusions (amount)participants will be followed for the duration of ICU stay, an expected average of 2 days/ And participants will be followed for the duration of hospital stay, an expected average of 3 weeksThe amount of red blood cell transfusions the patient receive pre, peri and postoperatively during their stay in the hospital

Countries

Netherlands

Contacts

Primary ContactDorien Kimenai, Bsc
dkimenai@amphia.nl
Backup ContactThierry Scohy, MD, PhD
tscohy@amphia.nl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026